Safety of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Two-Year Interim Safety Results of the 0.2 µg/Day Fluocinolone Acetonide Intravitreal Implant for the Treatment of Diabetic Macular Oedema: The Observational PALADIN Study
Br J Ophthalmol 2020 May 27;[EPub Ahead of Print], SE Mansour, DF Kiernan, DB Roth, D Eichenbaum, NM Holekamp, S Kaba, E WertsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.